To experience fado, the mournful folk music born of Lisbon’s oldest neighbourhoods, is to tap into centuries of history and ...

One of BC’s most beloved and respected music retailers, Tapestry Music, has a new location and it's hosting a 3-day grand ...

After more than a decade, the Korean pop-rock band CNBLUE returned to Los Angeles for their VOYAGE into X North America tour ...

The latest count of votes Tuesday night had Imperial Beach Mayor Paloma Aguirre with an insurmountable lead Tuesday evening ...

Live music is still your best entertainment value, when it comes to soul-feeding and body-rumbling. Here, in no particular ...

PRICING MISSTEP Novo also drew backlash from insurers, doctors and patients for launching Wegovy in the U.S. at more than $1,300 per month, about $350 more than Ozempic.

COPENHAGEN (Reuters) -Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, leaving the Danish ...

Ashley McBryde named her guitar Dinah because she played her a lot in the kitchen. Read where Eddie Van Halen's "Frankenstein" guitar ended up after his death. Willie Nelson has been playing his ...

Novo Nordisk's press release stated that the "FDA action date to decide on the Wegovy ® oral formulation NDA will be in Q4 2025." Thus, if approved, we can expect a launch in 2026.

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, leaving the Danish drugmaker in a more ...

Novo Nordisk A/S (NYSE:NVO) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company discontinued its partnership with Hims & Hers concerning selling its weight-loss ...